Allurion Technologies (ALUR) Total Liabilities (2022 - 2026)
Allurion Technologies (ALUR) posted Total Liabilities of $91.9 million for Q1 2026, down 1.14% on a QoQ basis from $93.0 million in Q4 2025, and down 15.06% year-over-year from $108.2 million in Q1 2025.
Allurion Technologies (ALUR) Total Liabilities (2022 - 2026) Analysis & Trends
Allurion Technologies' Total Liabilities history runs 5 years deep, the most recent figure standing at $91.9 million for Q1 2026.
- Quarterly Total Liabilities fell 15.06% year-over-year to $91.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $91.9 million (down 15.06% YoY) and the FY2025 annual result came in at $93.0 million, down 16.09% from the prior year.
- Total Liabilities was $91.9 million for Q1 2026 at Allurion Technologies, down from $93.0 million in the prior quarter.
- Across five years, Total Liabilities topped out at $173.4 million in Q3 2023 and bottomed at $83.7 million in Q4 2022.
- A 5-year average of $113.7 million and a median of $110.8 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities soared 70.89% — and 2024, when it plunged 33.98%.
- Allurion Technologies' Total Liabilities stood at $83.7 million in 2022, then surged by 70.89% to $143.0 million in 2023, then fell by 22.53% to $110.8 million in 2024, then slipped by 16.09% to $93.0 million in 2025, then decreased by 1.14% to $91.9 million in 2026.
- Business Quant data shows ALUR's Total Liabilities at $91.9 million in Q1 2026, $93.0 million in Q4 2025, and $101.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 23.31 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.99 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.68 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 18.55 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.17 Bn |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | 91.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.91 Mn |
| Dec 31, 2025 | 92.96 Mn |
| Sep 30, 2025 | 101.07 Mn |
| Jun 30, 2025 | 92.15 Mn |
| Mar 31, 2025 | 108.20 Mn |
| Dec 31, 2024 | 110.79 Mn |
| Sep 30, 2024 | 114.51 Mn |
| Jun 30, 2024 | 117.13 Mn |
| Mar 31, 2024 | 126.15 Mn |
| Dec 31, 2023 | 143.01 Mn |
| Sep 30, 2023 | 173.44 Mn |
| Jun 30, 2023 | 123.37 Mn |
| Dec 31, 2022 | 83.68 Mn |